News Release
Fourth quarter 2018 net income was
Highlights for ongoing operations for the fourth quarter of 2018:
-
Operating profit from ongoing operations for PE Films of
$9.3 million was$1.3 million lower than the fourth quarter of 2017 -
Operating profit from ongoing operations for Aluminum Extrusions of
$13.5 million was$4.3 million higher than the fourth quarter of 2017 -
Operating profit from ongoing operations for Flexible Packaging Films
of
$3.3 million was$2.5 million higher than the fourth quarter of 2017
Mr. Gottwald continued, “The near-term uncertainty relates to Personal
Care’s transition from one large customer to new products with new
customers, especially in elastic films. We know we’ll see a large
negative income impact in 2019 and 2020 during this transition, but I am
hopeful that a more diversified and profitable business will emerge.
John Steitz’s expertise will be particularly helpful in supporting
Personal Care through this transition. I have great confidence in John’s
ability to lead
On
OPERATIONS REVIEW
PE Films
PE Films is comprised of personal care materials, surface protection films, polyethylene overwrap films and films for other markets. A summary of fourth quarter and full year operating results from ongoing operations for PE Films is provided below:
Three Months Ended | Favorable/ | Year Ended | Favorable/ | |||||||||||||||||||
(In thousands, except percentages) | December 31, | (Unfavorable) | December 31, | (Unfavorable) | ||||||||||||||||||
2018 | 2017 | % Change | 2018 | 2017 | % Change | |||||||||||||||||
Sales volume (lbs) | 29,064 | 35,076 | (17.1 | )% | 123,583 | 138,999 | (11.1 | )% | ||||||||||||||
Net sales | $ | 80,311 | $ | 86,686 | (7.4 | )% | $ | 332,488 | $ | 352,459 | (5.7 | )% | ||||||||||
Operating profit from ongoing operations | $ | 9,324 | $ | 10,581 | (11.9 | )% | $ | 36,181 | $ | 41,546 | (12.9 | )% | ||||||||||
Fourth Quarter 2018 Results vs. Fourth Quarter 2017 Results
Net sales (sales less freight) in the fourth quarter of 2018 decreased
by
Net sales in Surface Protection declined slightly in the fourth quarter of 2018 versus 2017 primarily due to lower volume that the Company continues to believe resulted from customer inventory corrections, partially offset by a one-time benefit from replacement sales associated with prior quality claims and added volume from new customers. Surface Protection had particularly strong sales in the fourth quarter of 2017. The Company estimates that the previously disclosed customer product transition to alternative processes or materials, which is discussed further in the subsection below, had a near neutral impact on sales as related lower volume was offset by volume-based higher selling prices.
Operating profit from ongoing operations in the fourth quarter of 2018
decreased by
-
Lower contribution to profits from Personal Care primarily due to
lower volume and unfavorable product mix (
$3.8 million ), partially offset by the net favorable impact of the timing of resin cost passthroughs ($0.7 million ), productivity improvements ($0.6 million ) and lower selling, general and administrative costs ($0.5 million ); -
Slightly higher contribution to profits from Surface Protection,
primarily due to a one-time benefit from replacement sales associated
with prior quality claims (
$1.9 million ), partially offset by lower volume net of volume-based higher selling prices (net unfavorable impact of$1.6 million ); and -
Realized cost savings associated with the North American consolidation
of our PE Films manufacturing facilities completed in 2017 (
$0.5 million ).
In
Customer Product Transitions in Personal Care and Surface Protection
During
Personal Care has increased its annual R&D spending by approximately
The Personal Care component of PE Films had operating profit from
ongoing operations plus depreciation and amortization in the fourth
quarter of 2018 of
Because of the significance of the customer transition discussed above,
the Company performed an asset recoverability test and goodwill
impairment analysis for the Personal Care component of PE Films. The
Company’s analysis concluded that the fair value of the Personal Care
reporting unit was less than its carrying value. Accordingly, the
goodwill associated with Personal Care of
The Surface Protection component of PE Films supports manufacturers of optical and other specialty substrates used in flat panel display products. These films are primarily used by customers to protect components of displays in the manufacturing and transportation processes and then discarded.
The Company previously reported the risk that a portion of its film
products used in surface protection applications will be made obsolete
by possible future customer product transitions to less costly
alternative processes or materials. These transitions could possibly be
fully implemented by the fourth quarter of 2019. When fully implemented,
the Company estimates that the annualized adverse impact on future
operating profit from this customer shift will be approximately
Full Year 2018 Results vs. Full Year 2017 Results
Net sales in 2018 decreased by
- Lower sales in Personal Care primarily due to the same factors described in the fourth quarter discussion; and
- Slightly lower sales in Surface Protection caused by lower volume and the adverse impact of quality claims, partially offset by higher volume-based selling prices.
Operating profit from ongoing operations in 2018 decreased by
-
Lower contribution to profits from Personal Care, primarily due to
lower volume and unfavorable product mix (
$9.3 million ), partially offset by volume-based higher selling pricing ($2.2 million ), lower fixed and selling, general and administrative costs ($1.1 million ), the timing of resin cost passthroughs ($0.7 million ), productivity improvements ($0.3 million ) and net favorable impact from the change in U.S. Dollar value of currencies for operations outside of the U.S. ($0.8 million ); -
Lower contribution to profits from Surface Protection, primarily due
to lower volumes and unfavorable product mix (
$4.1 million ), the adverse impact of quality claims ($1.3 million ), higher fixed and other manufacturing costs ($1.6 million ), higher research and development spending and selling, general and administrative costs ($0.4 million ) and higher freight costs ($0.5 million ), partially offset by volume-based higher selling prices ($4.4 million ); and -
Realized cost savings associated with the North American consolidation
of our PE Films manufacturing facilities completed in 2017 (
$2.4 million ).
Capital Expenditures and Depreciation
Capital expenditures in PE Films were
From 2016 to 2018, the Company spent annually on average approximately
Depreciation expense was
Flexible Packaging Films
Flexible Packaging Films, which is also referred to as Terphane, produces polyester-based films for use in packaging applications that have specialized properties, such as heat resistance, strength, barrier protection and the ability to accept high-quality print graphics. A summary of fourth quarter and full year operating results from ongoing operations for Flexible Packaging Films is provided below:
Three Months Ended |
Favorable/ |
Year Ended |
Favorable/ |
|||||||||||||||||||
(In thousands, except percentages) | December 31, | December 31, | ||||||||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||||||||
Sales volume (lbs) | 24,718 | 23,656 | 4.5 | % | 98,994 | 89,325 | 10.8 | % | ||||||||||||||
Net sales | $ | 33,364 | $ | 28,430 | 17.4 | % | $ | 123,830 | $ | 108,355 | 14.3 | % | ||||||||||
Operating profit (loss) from ongoing operations | $ | 3,274 | $ | 766 | 327.4 | % | $ | 9,892 | $ | (2,626 | ) | n/a | ||||||||||
Fourth Quarter 2018 Results vs. Fourth Quarter 2017 Results
Net sales in the fourth quarter of 2018 increased 17.4% versus the
fourth quarter of 2017 primarily due to higher sales volume and
increased selling prices associated with the pass-through of higher
resin costs. The higher sales volume was supported by increased
production capacity for Terphane’s Brazilian operations, resulting from
the re-start in
Terphane’s operating profit from ongoing operations in the fourth
quarter of 2018 increased by
-
Significantly lower depreciation and amortization of
$2.2 million resulting from the$101 million non-cash asset impairment loss recognized in the fourth quarter of 2017; -
A benefit from higher volume (
$1.4 million ) and favorable tax incentives ($0.6 million ), partially offset by the unfavorable impact of mix and higher resin costs, net of higher selling prices ($0.2 million ); -
Higher fixed and other manufacturing costs and selling, general and
administrative costs, primarily related to higher volume (
$1.2 million ); -
Favorable foreign currency translation of Real-denominated operating
costs (
$0.7 million ), which was offset by a$0.5 million loss on foreign currency forward contracts that partially hedged Real-denominated operating costs; and -
Unfavorable net foreign currency transaction impact (
$0.6 million ) resulting from foreign currency transaction losses of$0.4 million in the fourth quarter of 2018 and gains of$0.2 million in the fourth quarter of 2017.
Terphane’s quarterly financial results have been volatile, and the
Company expects continued uncertainty and volatility until industry
capacity utilization and the competitive dynamics in
Full Year 2018 Results vs. Full Year 2017 Results
Net sales in 2018 increased versus 2017 primarily due to higher sales
volume and increased selling prices associated with the pass-through of
higher resin costs. The higher sales volume was supported by the
increase in production capacity in
Terphane had operating profit from ongoing operations in 2018 of
-
Significantly lower depreciation and amortization of
$8.9 million resulting from the$101 million non-cash asset impairment loss recognized in the fourth quarter of 2017; -
A benefit from higher volume (
$5.5 million ) and favorable tax incentives ($1.3 million ), partially offset by the unfavorable impact of mix and higher resin costs, net of higher selling prices ($2.2 million ); -
Higher fixed and other manufacturing costs and selling, general and
administrative costs, primarily related to higher volume (
$2.0 million ); -
Favorable foreign currency translation of Real-denominated operating
costs (
$3.2 million ), which was offset by a$1.7 million loss on foreign currency forward contracts that partially hedged Real-denominated operating costs; and -
Unfavorable net foreign currency transaction impact (
$0.6 million ) resulting from foreign currency transaction losses of$0.8 million in 2018 and losses of$0.2 million in 2017.
Capital Expenditures, Depreciation & Amortization
Capital expenditures in Flexible Packaging were
Aluminum Extrusions
Aluminum Extrusions, which includes Bonnell Aluminum and its operating divisions, AACOA and Futura, produces high-quality, soft-alloy and medium-strength aluminum extrusions primarily for the following markets: building and construction, automotive, and specialty, which consists of consumer durables, machinery and equipment, electrical and distribution end-use products.
A summary of fourth quarter and full year results for Aluminum Extrusions is provided below:
Three Months Ended | Favorable/ | Year Ended | Favorable/ | |||||||||||||||||||
(In thousands, except percentages) | December 31, | (Unfavorable) | December 31, | (Unfavorable) | ||||||||||||||||||
2018 | 2017 | % Change | 2018 | 2017 | % Change | |||||||||||||||||
Sales volume (lbs) * | 60,674 | 50,564 | 20.0 | % | 190,696 | 176,269 | 8.2 | % | ||||||||||||||
Net sales | $ | 152,672 | $ | 121,877 | 25.3 | % | $ | 573,126 | $ | 466,833 | 22.8 | % | ||||||||||
Operating profit from ongoing operations | $ | 13,527 | $ | 9,253 | 46.2 | % | $ | 48,613 | $ | 43,454 | 11.9 | % | ||||||||||
*Sales volume for the years ended December 31, 2018 and 2017 excludes sales volume of 33,170 lbs. and 23,166 lbs., respectively, associated with Futura Industries Corporation (“Futura”), which was acquired on February 15, 2017. |
||||||||||||||||||||||
Fourth Quarter 2018 Results vs. Fourth Quarter 2017 Results
Net sales in the fourth quarter of 2018 increased versus 2017 primarily due to higher sales volume and an increase in average selling prices from the pass-through of higher market-driven raw material costs.
Sales volume in the fourth quarter of 2018 increased by 20% versus 2017
due to higher volume in all of Bonnell’s primary markets. Higher average
net selling prices, primarily attributed to an increase in aluminum
market prices, had a favorable impact on net sales of
Operating profit from ongoing operations in the fourth quarter of 2018
increased by
-
Higher sales volume (
$5.1 million ), slightly offset by less favorable mix associated with continued inefficiencies at theNiles, Michigan facility ($0.6 million ); -
A benefit for inventories accounted for under the LIFO method (
$1.0 million ) in the fourth quarter of 2018 versus a charge ($1.3 million ) in the fourth quarter of 2017; -
Higher costs associated with externally-sourced metal purchases (
$0.9 million ) due to cast house maintenance; and -
Higher headcount for manufacturing management associated with higher
volume (
$0.8 million ) and higher freight and selling, general and administrative costs ($0.8 million ).
Full Year 2018 Results vs. Full Year 2017 Results
Net sales in 2018 increased versus 2017 primarily due to higher volume
and an increase in average selling prices from the pass-through of
higher market-driven raw material costs. Futura contributed
Volume on an organic basis (which excludes the impact of the Futura acquisition) increased by 8.2% in 2018 versus 2017 due to higher volume in all of Aluminum Extrusion’s primary markets.
Operating profit from ongoing operations in 2018 increased by
-
Higher volume (
$5.1 million ) and favorable mix ($5.8 million ), which were offset by higher employee-related costs ($5.2 million ), higher supplies and maintenance ($2.3 million ), higher freight ($1.7 million ), higher utilities, primarily in the first quarter of 2018 at theNewnan, Georgia facility ($0.9 million ), and higher depreciation ($0.9 million ).
The Company continues to focus on fixing inefficiencies associated with
the new extrusion line at its
Capital Expenditures and Depreciation & Amortization
Capital expenditures for Aluminum Extrusions were
Corporate Expenses, Investments, Interest and Taxes
Pension expense was
Interest expense decreased to
During 2018, the Company recognized consolidated income tax expense of
Tredegar’s approximately 20% ownership in kaleo, Inc. (“kaléo”), which
is accounted for under the fair value method, was estimated at a value
of
CAPITAL STRUCTURE
Total debt was
FORWARD-LOOKING AND CAUTIONARY STATEMENTS
Some of the information contained in this press release may constitute “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. When we use the words “believe,” “estimate,” “anticipate,” “expect,” “project,” “likely,” “may” and similar expressions, we do so to identify forward-looking statements. Such statements are based on our then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. It is possible that our actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these forward-looking statements. Factors that could cause actual results to differ from expectations include, without limitation, the following:
- loss or gain of sales to significant customers on which our business is highly dependent;
- inability to achieve sales to new customers to replace lost business;
- ability to develop and deliver new products at competitive prices;
- failure of our customers to achieve success or maintain market share;
- failure to protect our intellectual property rights;
- risks of doing business in countries outside the U.S. that affect our substantial international operations;
- political, economic, and regulatory factors concerning our products;
- uncertain economic conditions in countries in which we do business;
- competition from other manufacturers, including manufacturers in lower-cost countries and manufacturers benefiting from government subsidies;
- impact of fluctuations in foreign exchange rates;
- a change in the amount of our underfunded defined benefit (pension) plan liability;
- an increase in the operating costs incurred by our operating companies, including, for example, the cost of raw materials and energy;
- inability to successfully identify, complete or integrate strategic acquisitions; failure to realize the expected benefits of such acquisitions and assumption of unanticipated risks in such acquisitions;
- disruption to our manufacturing facilities;
- occurrence or threat of extraordinary events, including natural disasters and terrorist attacks;
- an information technology system failure or breach;
- volatility and uncertainty of the value of our cost-basis investment in kaléo;
- the impact of new tariffs or duties imposed as a result of rising trade tensions between the U.S. and other countries;
- failure to establish and maintain effective internal control over financial reporting;
and the other factors discussed in the reports
To the extent that the financial information portion of this press release contains non-GAAP financial measures, it also presents both the most directly comparable financial measures calculated and presented in accordance with GAAP and a quantitative reconciliation of the difference between any such non-GAAP measures and such comparable GAAP financial measures. Reconciliations of non-GAAP financial measures are provided in the Notes to the Financial Tables included with this press release and can also be found within “Presentations” in the “Investors” section of our website, www.tredegar.com.
Tredegar Corporation | ||||||||||||||||
Condensed Consolidated Statements of Income | ||||||||||||||||
(In Thousands, Except Per-Share Data) | ||||||||||||||||
(Unaudited) | ||||||||||||||||
Three Months Ended | Year Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
Sales | $ | 275,707 | $ | 245,836 | $ | 1,065,471 | $ | 961,330 | ||||||||
Other income (expense), net (b) (d) (e) | 18,927 | 13,658 | 30,459 | 51,713 | ||||||||||||
294,634 | 259,494 | 1,095,930 | 1,013,043 | |||||||||||||
Cost of goods sold (b) | 218,521 | 197,995 | 849,756 | 767,550 | ||||||||||||
Freight | 9,360 | 8,843 | 36,027 | 33,683 | ||||||||||||
Selling, R&D and general expenses (b) | 26,432 | 25,794 | 103,990 | 101,673 | ||||||||||||
Amortization of identifiable intangibles | 900 | 1,647 | 3,976 | 6,198 | ||||||||||||
Pension and postretirement benefits | 2,597 | 2,548 | 10,406 | 10,193 | ||||||||||||
Interest expense | 1,163 | 1,591 | 5,702 | 6,170 | ||||||||||||
Asset impairments and costs associated with exit and |
1,113 | 101,835 | 2,913 | 102,488 | ||||||||||||
Goodwill impairment charge (c) | — | — | 46,792 | — | ||||||||||||
260,086 | 340,253 | 1,059,562 | 1,027,955 | |||||||||||||
Income (loss) before income taxes | 34,548 | (80,759 | ) | 36,368 | (14,912 | ) | ||||||||||
Income tax expense (benefit) (f) | 8,391 | (62,830 | ) | 11,526 | (53,163 | ) | ||||||||||
Net income (loss) | $ | 26,157 | $ | (17,929 | ) | $ | 24,842 | $ | 38,251 | |||||||
Earnings (loss) per share: | ||||||||||||||||
Basic | $ | 0.79 | $ | (0.54 | ) | $ | 0.75 | $ | 1.16 | |||||||
Diluted | $ | 0.79 | $ | (0.54 | ) | $ | 0.75 | $ | 1.16 | |||||||
Shares used to compute earnings (loss) per share: | ||||||||||||||||
Basic | 33,103 | 32,948 | 33,068 | 32,946 | ||||||||||||
Diluted | 33,112 | 32,948 | 33,092 | 32,951 | ||||||||||||
Tredegar Corporation | ||||||||||||||||
Net Sales and Operating Profit by Segment | ||||||||||||||||
(In Thousands) | ||||||||||||||||
(Unaudited) | ||||||||||||||||
Three Months Ended | Year Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
Net Sales | ||||||||||||||||
PE Films | $ | 80,311 | $ | 86,686 | $ | 332,488 | $ | 352,459 | ||||||||
Flexible Packaging Films | 33,364 | 28,430 | 123,830 | 108,355 | ||||||||||||
Aluminum Extrusions | 152,672 | 121,877 | 573,126 | 466,833 | ||||||||||||
Total net sales | 266,347 | 236,993 | 1,029,444 | 927,647 | ||||||||||||
Add back freight | 9,360 | 8,843 | 36,027 | 33,683 | ||||||||||||
Sales as shown in the Consolidated Statements of Income | $ | 275,707 | $ | 245,836 | $ | 1,065,471 | $ | 961,330 | ||||||||
Operating Profit | ||||||||||||||||
PE Films: | ||||||||||||||||
Ongoing operations | $ | 9,324 | $ | 10,581 | $ | 36,181 | $ | 41,546 | ||||||||
Plant shutdowns, asset impairments, restructurings and |
(1,363 | ) | (1,015 | ) | (5,905 | ) | (4,905 | ) | ||||||||
Goodwill impairment charge (c) | — | — | (46,792 | ) | — | |||||||||||
Flexible Packaging Films: | ||||||||||||||||
Ongoing operations | 3,274 | 766 | 9,892 | (2,626 | ) | |||||||||||
Plant shutdowns, asset impairments, restructurings and |
(45 | ) | (101,254 | ) | (45 | ) | (89,398 | ) | ||||||||
Aluminum Extrusions: | ||||||||||||||||
Ongoing operations | 13,527 | 9,253 | 48,613 | 43,454 | ||||||||||||
Plant shutdowns, asset impairments, restructurings and |
(109 | ) | 3,468 | (505 | ) | 321 | ||||||||||
Total | 24,608 | (78,201 | ) | 41,439 | (11,608 | ) | ||||||||||
Interest income | 79 | 39 | 369 | 209 | ||||||||||||
Interest expense | 1,163 | 1,591 | 5,702 | 6,170 | ||||||||||||
Gain on investment in kaléo accounted for under fair value |
18,700 | 9,000 | 30,600 | 33,800 | ||||||||||||
Loss on sale of investment property (e) | (38 | ) | — | (38 | ) | — | ||||||||||
Unrealized loss on investment property (e) | — | — | 186 | — | ||||||||||||
Stock option-based compensation costs | 415 | 111 | 1,221 | 264 | ||||||||||||
Corporate expenses, net (b) | 7,223 | 9,895 | 28,893 | 30,879 | ||||||||||||
Income (loss) before income taxes | 34,548 | (80,759 | ) | 36,368 | (14,912 | ) | ||||||||||
Income tax expense (benefit) (f) | 8,391 | (62,830 | ) | 11,526 | (53,163 | ) | ||||||||||
Net income (loss) | $ | 26,157 | $ | (17,929 | ) | $ | 24,842 | $ | 38,251 | |||||||
Tredegar Corporation | |||||||
Condensed Consolidated Balance Sheets | |||||||
(In Thousands) | |||||||
(Unaudited) | |||||||
December 31, 2018 | December 31, 2017 | ||||||
Assets | |||||||
Cash & cash equivalents | $ | 34,397 | $ | 36,491 | |||
Accounts & other receivables, net | 124,727 | 120,135 | |||||
Income taxes recoverable | 6,783 | 32,080 | |||||
Inventories | 93,810 | 86,907 | |||||
Prepaid expenses & other | 9,564 | 8,224 | |||||
Total current assets | 269,281 | 283,837 | |||||
Property, plant & equipment, net | 228,369 | 223,091 | |||||
Investment in kaléo (cost basis of $7,500) | 84,600 | 54,000 | |||||
Identifiable intangible assets, net | 36,295 | 40,552 | |||||
Goodwill | 81,404 | 128,208 | |||||
Deferred income tax assets | 3,412 | 16,636 | |||||
Other assets | 4,012 | 9,419 | |||||
Total assets | $ | 707,373 | $ | 755,743 | |||
Liabilities and Shareholders’ Equity | |||||||
Accounts payable | $ | 112,758 | $ | 108,391 | |||
Accrued expenses | 42,495 | 42,433 | |||||
Total current liabilities | 155,253 | 150,824 | |||||
Long-term debt | 101,500 | 152,000 | |||||
Pension and other postretirement benefit obligations, net | 88,124 | 98,837 | |||||
Deferred income tax liabilities | — | 2,123 | |||||
Other noncurrent liabilities | 7,639 | 8,179 | |||||
Shareholders’ equity | 354,857 | 343,780 | |||||
Total liabilities and shareholders’ equity | $ | 707,373 | $ | 755,743 | |||
Tredegar Corporation | ||||||||
Condensed Consolidated Statement of Cash Flows | ||||||||
(In Thousands) | ||||||||
(Unaudited) | ||||||||
Year Ended December 31, | ||||||||
2018 | 2017 | |||||||
Cash flows from operating activities: | ||||||||
Net income | $ | 24,842 | $ | 38,251 | ||||
Adjustments for noncash items: | ||||||||
Depreciation | 29,828 | 34,079 | ||||||
Amortization of identifiable intangibles | 3,976 | 6,198 | ||||||
Goodwill impairment charge | 46,792 | — | ||||||
Deferred income taxes | 8,626 | (36,414 | ) | |||||
Accrued pension and postretirement benefits | 10,406 | 10,193 | ||||||
(Gain) loss on investment in kaléo accounted for under the fair value method | (30,600 | ) | (33,800 | ) | ||||
Loss on asset impairments | 223 | 101,282 | ||||||
(Gain) loss on sale of assets | (46 | ) | 553 | |||||
Gain from insurance recoveries | — | (5,261 | ) | |||||
Changes in assets and liabilities: | ||||||||
Accounts and other receivables | (11,883 | ) | (10,566 | ) | ||||
Inventories | (9,577 | ) | (9,128 | ) | ||||
Income taxes recoverable/payable | 25,018 | (24,449 | ) | |||||
Prepaid expenses and other | (1,924 | ) | (784 | ) | ||||
Accounts payable and accrued expenses | 5,571 | 21,123 | ||||||
Pension and postretirement benefit plan contributions | (8,907 | ) | (5,829 | ) | ||||
Other, net | 5,449 | 2,767 | ||||||
Net cash provided by operating activities | 97,794 | 88,215 | ||||||
Cash flows from investing activities: | ||||||||
Capital expenditures | (40,814 | ) | (44,362 | ) | ||||
Acquisitions, net of cash acquired | — | (87,110 | ) | |||||
Return of escrowed funds relating to acquisition earn-out | 4,250 | — | ||||||
Sale of investment property | 1,384 | — | ||||||
Insurance proceeds from cast house explosion | — | 5,739 | ||||||
Proceeds from the sale of assets and other | 1,098 | 129 | ||||||
Net cash used in investing activities | (34,082 | ) | (125,604 | ) | ||||
Cash flows from financing activities: | ||||||||
Borrowings | 76,750 | 190,750 | ||||||
Debt principal payments | (127,250 | ) | (133,750 | ) | ||||
Dividends paid | (14,592 | ) | (14,532 | ) | ||||
Proceeds from exercise of stock options and other | 1,004 | 695 | ||||||
Net cash provided by (used) in financing activities | (64,088 | ) | 43,163 | |||||
Effect of exchange rate changes on cash | (1,718 | ) | 1,206 | |||||
Increase (decrease) in cash and cash equivalents | (2,094 | ) | 6,980 | |||||
Cash and cash equivalents at beginning of period | 36,491 | 29,511 | ||||||
Cash and cash equivalents at end of period | $ | 34,397 | $ | 36,491 | ||||
Notes to the Financial Tables
(Unaudited)
(a) | Tredegar’s presentation of net income from ongoing operations and earnings per share from ongoing operations are non-GAAP financial measures that exclude the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges and other items (which includes unrealized gains and losses for an investment accounted for under the fair value method), which have been presented separately and removed from net income and diluted earnings per share as reported under GAAP. Net income from ongoing operations and earnings per share from ongoing operations are key financial and analytical measures used by management to gauge the operating performance of Tredegar’s ongoing operations. They are not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income or earnings per share as defined by GAAP. They exclude items that management believes do not relate to Tredegar’s ongoing operations. A reconciliation to net income from ongoing operations for the three and twelve months ended December 31, 2018 and 2017 is shown below: |
(In millions, except per share data) |
Three Months Ended |
Twelve Months Ended |
||||||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||||||
Net income (loss) as reported under GAAP | $ | 26.2 | $ | (17.9 | ) | $ | 24.8 | $ | 38.3 | |||||||||||
After-tax effects of: | ||||||||||||||||||||
Losses associated with plant shutdowns, asset impairments and |
||||||||||||||||||||
Terphane asset impairment loss | — | 87.2 | — | 87.2 | ||||||||||||||||
Other | 1.2 | 0.5 | 3.8 | 1.4 | ||||||||||||||||
(Gains) losses from sale of assets and other: | ||||||||||||||||||||
Unrealized (gain) loss associated with the investment in kaléo | (14.7 | ) | (5.8 | ) | (23.9 | ) | (24.0 | ) | ||||||||||||
Gain associated with the settlement of an escrow agreement | — | — | — | (11.9 | ) | |||||||||||||||
Tax benefit from Terphane worthless stock deductions | — | (53.4 | ) | — | (61.4 | ) | ||||||||||||||
Tax benefit from adjustments of net deferred income tax liabilities |
— | (4.4 | ) | — | (4.4 | ) | ||||||||||||||
Other | 1.5 | 0.2 | 4.4 | 4.9 | ||||||||||||||||
Goodwill impairment charge | — | — | 38.2 | — | ||||||||||||||||
Net income from ongoing operations | $ | 14.2 | $ | 6.4 | $ | 47.3 | $ | 30.1 | ||||||||||||
Earnings (loss) per share as reported under GAAP (diluted) | 0.79 | (0.54 | ) | 0.75 | 1.16 | |||||||||||||||
After-tax effects per diluted share of: | ||||||||||||||||||||
Losses associated with plant shutdowns, asset impairments and |
||||||||||||||||||||
Terphane asset impairment loss | — | 2.65 | — | 2.65 | ||||||||||||||||
Other |
0.04 | 0.01 | 0.12 | 0.04 | ||||||||||||||||
(Gains) losses from sale of assets and other: | ||||||||||||||||||||
Unrealized (gain) loss associated with the investment in kaléo | (0.44 | ) | (0.18 | ) | (0.72 | ) | (0.73 | ) | ||||||||||||
Gain associated with the settlement of an escrow agreement | — | — | — | (0.36 | ) | |||||||||||||||
Tax benefit from Terphane worthless stock deductions | — | (1.62 | ) | — | (1.86 | ) | ||||||||||||||
Tax benefit from adjustments of net deferred income tax liabilities |
— | (0.13 | ) | — | (0.13 | ) | ||||||||||||||
Other | 0.04 | 0.01 | 0.13 | 0.14 | ||||||||||||||||
Goodwill impairment charge | — | — | 1.15 | — | ||||||||||||||||
Earnings per share from ongoing operations (diluted) | 0.43 | 0.20 | 1.43 | 0.91 | ||||||||||||||||
Reconciliations of the pre-tax and post-tax balances attributed to net income (loss) are shown in Note (h). |
||||||||||||||||||||
(b) | Losses associated with plant shutdowns, asset impairments, restructurings and other items in the fourth quarter and full year of 2018 and 2017 detailed below are shown in the statement of net sales and operating profit by segment and are included in “Asset impairments and costs associated with exit and disposal activities, net of adjustments” in the condensed consolidated statements of income, unless otherwise noted. | |||
Plant shutdowns, asset impairments, restructurings and other in the fourth quarter of 2018 include: | ||||
• |
Pretax charges of $0.9 million associated with the shutdown of PE Films’ manufacturing facility in Shanghai, China, which consists of severance and other employee-related costs of $0.5 million ($0.1 million included in “Cost of goods sold” in the condensed consolidated statements of income), accelerated depreciation of $0.1 million (included in “Cost of goods sold” in the condensed consolidated statements of income) and other facility consolidation-related expenses of $0.3 million; | |||
• |
Pretax charges of $0.5 million associated with business development projects (included in “Selling, R&D and general expenses” in the condensed consolidated statements of income and “Corporate expenses, net” in the statement of net sales and operating profit by segment); | |||
• |
Pretax charges of $0.3 million for severance and other employee-related costs associated with restructurings in PE Films; | |||
• |
Pretax charges of $0.3 million related to estimated excess costs associated with the ramp-up of new product offerings and additional expenses related to strategic capacity expansion projects by PE Films (included in “Cost of goods sold” in the condensed consolidated statements of income); | |||
• |
Pretax charges of $0.5 million for professional fees associated with the implementation of new accounting guidance and analysis and revisions to the Company’s internal control over financial reporting (included in “Selling, R&D and general expenses” in the condensed consolidated statements of income); | |||
• |
Pretax income of $0.3 million (included in “Other income (expense), net” in the condensed consolidated statements of income) from the reversal of a PE Films’ contingent liability related to the acquisition of Bright View Technologies; | |||
• |
Pretax charges of $0.1 million related to expected future environmental costs at the aluminum extrusions manufacturing facility in Carthage, Tennessee (included in “Cost of goods sold” in the condensed consolidated statements of income); and | |||
• |
Pretax charges of $0.1 million related to a fire that occurred in the fourth quarter of 2018 at the PE Films facility in Retsag, Hungary (included in “Selling, R&D and general expenses” in the condensed consolidated statements of income). | |||
Plant shutdowns, asset impairments, restructurings and other charges in 2018 include: | ||||
• |
Pretax charges of $3.3 million associated with the shutdown of PE Films’ manufacturing facility in Shanghai, China, which consists of severance and other employee-related costs of $2.2 million ($0.4 million included in “Cost of goods sold” in the condensed consolidated statements of income), accelerated depreciation of $0.6 million (included in “Cost of goods sold” in the condensed consolidated statements of income) and other facility consolidation-related expenses of $0.5 million ($0.1 million included in “Cost of goods sold” in the condensed consolidated statements of income); | |||
• |
Pretax charges of $2.0 million related to estimated excess costs associated with the ramp-up of new product offerings and additional expenses related to strategic capacity expansion projects by PE Films (included in “Cost of goods sold” in the condensed consolidated statements of income); | |||
• |
Pretax charges of $0.8 million for professional fees associated with the Terphane Limitada worthless stock deduction, the impairment of assets of Flexible Packaging Films, determining the effect of the new U.S. federal income tax law, and a market study for PE Films (included in “Selling, R&D and general expenses” in the condensed consolidated statements of income); | |||
• |
Pretax charges of $0.8 million for severance and other employee-related costs associated with restructurings in PE Films ($0.7 million) and Aluminum Extrusions ($0.1 million); | |||
• |
Pretax charges of $0.5 million associated with business development projects (included in “Selling, R&D and general expenses” in the condensed consolidated statements of income and “Corporate expenses, net” in the statement of net sales and operating profit by segment); | |||
• |
Pretax charges of $0.3 million related to expected future environmental costs at the aluminum extrusions manufacturing facility in Carthage, Tennessee (included in “Cost of goods sold” in the condensed consolidated statements of income); | |||
• |
Pretax charges of $0.5 million for professional fees associated with the implementation of new accounting guidance and analysis and revisions to the Company’s internal control over financial reporting (included in “Selling, R&D and general expenses” in the condensed consolidated statements of income); | |||
• |
Pretax income of $0.3 million (included in “Other income (expense), net” in the condensed consolidated statements of income) from the reversal of a PE Films’ contingent liability related to the acquisition of Bright View Technologies; | |||
• |
Pretax charges of $0.1 million related to wind damage that occurred in the third quarter of 2018 at the aluminum extrusions manufacturing facility in Elkhart, Indiana (included in “Selling, R&D and general expenses” in the condensed consolidated statements of income); and | |||
• |
Pretax charges of $0.1 million related to a fire that occurred in the fourth quarter of 2018 at the PE Films facility in Retsag, Hungary (included in “Selling, R&D and general expenses” in the condensed consolidated statements of income). | |||
Plant shutdowns, asset impairments, restructurings and other in the fourth quarter of 2017 include: | ||||
• |
Pretax charges of $101.3 million related to the impairment of assets at Flexible Packaging Films. During the fourth quarter of 2017, in conjunction with annual business planning as well as valuation activities and other efforts, the Company determined that the carrying value of Terphane’s remaining long-lived assets were impaired (Terphane’s goodwill was written off in 2015). Accordingly, the Company wrote down these assets based on an enterprise valuation for all of Terphane of approximately $30 million; | |||
• |
Pretax income of $5.1 million, related to the explosion that occurred in the second quarter of 2016 at the aluminum extrusions manufacturing facility in Newnan, Georgia, which includes the recognition of a gain on the involuntary conversion of an asset of $5.3 million for insurance proceeds used for the replacement of capital equipment (included in “Other income (expense), net” in the condensed consolidated statements of income), partially offset by excess production costs of $0.2 million (included in “Cost of goods sold” in the condensed consolidated statements of income); | |||
• |
Pretax charges of $0.6 million for estimated excess costs associated with the ramp-up of new product offerings and additional expenses related to strategic capacity expansion projects by PE Films (included in “Cost of goods sold” in the condensed consolidated statements of income); | |||
• |
Pretax charges of $1.5 million related to expected future environmental costs at the aluminum extrusions manufacturing facilities in Carthage, Tennessee and Newnan, Georgia (included in “Cost of goods sold” in the condensed consolidated statements of income); | |||
• |
Pretax charges of $0.8 million at Corporate related to expected future environmental costs at various shutdown facilities (included in “Cost of goods sold” in the condensed consolidated statements of income); | |||
• |
Pretax charges of $1.3 million associated with business development projects (included in “Selling, R&D and general expenses” in the condensed consolidated statements of income and “Corporate expenses, net” in the statement of net sales and operating profit by segment); | |||
• |
Pretax charges of $0.4 million for professional fees associated with the Terphane Limitada worthless stock deduction and impairment of assets of Flexible Packaging Films; | |||
• |
Pretax charges of $0.3 million associated with asset impairments at PE Films’ Hungary facility; and | |||
• |
Pretax charges of $0.3 million for severance and other employee-related costs associated with restructurings in PE Films ($0.1 million), Aluminum Extrusions ($0.1 million) and Corporate ($0.1 million) (included in “Corporate expenses, net” in the statement of net sales and operating profit by segment). | |||
Plant shutdowns, asset impairments, restructurings and other charges in 2017 include: | ||||
• |
Pretax charges of $101.3 million related to the impairment of assets at Flexible Packaging Films. During the fourth quarter of 2017, in conjunction with annual business planning as well as valuation activities and other efforts, the Company determined that the carrying value of Terphane’s remaining long-lived assets were impaired (Terphane’s goodwill was written off in 2015). Accordingly, the Company wrote down these assets based on an enterprise valuation for all of Terphane of approximately $30 million; | |||
• |
Pretax income of $11.9 million related to the settlement of an escrow arrangement established upon the acquisition of Terphane in 2011 (included in “Other income (expense), net” in the condensed consolidated statements of income). In settling the escrow arrangement, the Company assumed the risk of the claims (and associated legal fees) against which the escrow previously secured the Company. While the ultimate amount of such claims is unknown, the Company believes that it is reasonably possible that it could be liable for some portion of these claims, and currently estimates the amount of such future claims at approximately $3.5 million; | |||
• |
Pretax charges of $3.3 million related to the acquisition of Futura, i) associated with accounting adjustments of $1.7 million made to the value of inventory sold by Aluminum Extrusions after its acquisition of Futura (included in “Cost of goods sold” in the condensed consolidated statements of income), ii) acquisition costs of $1.5 million and iii) integration costs of $0.1 million (both ii and iii included in “Selling, R&D and general expenses” in the condensed consolidated statements of income), offset by pretax income of $0.7 million related to the fair valuation of an earn-out provision (included in “Other income (expense), net” in the condensed consolidated statements of income); |
|||
• |
Pretax charges of $4.1 million related to estimated excess costs associated with the ramp-up of new product offerings and additional expenses related to strategic capacity expansion projects by PE Films of $3.6 million and by Aluminum Extrusions of $0.5 million (both included in “Cost of goods sold” in the condensed consolidated statements of income); | |||
• |
Pretax income of $5.6 million related to the explosion that occurred in the second quarter of 2016 at the aluminum extrusions manufacturing facility in Newnan, Georgia, including the recognition of a gain on the involuntary conversion of an asset of $5.3 million for insurance proceeds used for the replacement of capital equipment (included in “Other income (expense), net” in the condensed consolidated statements of income) and the recovery of excess production costs of $0.6 million incurred in 2016 for which recovery from insurance carriers was not previously considered to be reasonably assured (included in “Cost of goods sold” in the condensed consolidated statements of income), partially offset by excess production costs of $0.2 million (included in “Cost of goods sold” in the condensed consolidated statements of income) and legal and consulting fees of $0.1 million (included in “Selling, R&D and general expenses” in the condensed consolidated statements of income); | |||
• |
Pretax charges of $0.8 million associated with the consolidation of domestic PE Films’ manufacturing facilities, which consists of asset impairments of $0.1 million, accelerated depreciation of $0.3 million (included in “Cost of goods sold” in the condensed consolidated statements of income) and other facility consolidation-related expenses of $0.5 million (included in “Cost of goods sold” in the condensed consolidated statements of income), offset by pretax income of $0.1 million related to a reduction of severance and other employee-related accrued costs; | |||
• |
Pretax charges of $2.4 million associated with business development projects (included in “Selling, R&D and general expenses” in the condensed consolidated statements of income and “Corporate expenses, net” in the statements of net sales and operating profit by segment); | |||
• |
Pretax charges of $1.9 million related to expected future environmental costs at the aluminum extrusions manufacturing facilities in Carthage, Tennessee and Newnan, Georgia (included in “Cost of goods sold” in the condensed consolidated statements of income); | |||
• |
Pretax charges of $0.8 million at Corporate related to expected future environmental costs at various shutdown facilities (included in “Cost of goods sold” in the condensed consolidated statements of income); | |||
• |
Pretax charges of $0.7 million for severance and other employee-related costs associated with restructurings in PE Films ($0.2 million), Aluminum Extrusions ($0.1 million) and Corporate ($0.4 million) (included in “Corporate expenses, net” in the statements of net sales and operating profit by segment); | |||
• |
Pretax charges of $0.4 million for professional fees associated with the Terphane Limitada worthless stock deduction and impairment of assets of Flexible Packaging Films; | |||
• |
Pretax charges of $0.3 million associated with asset impairments at PE Films’ Hungary facility; and | |||
• |
Pretax charges of $0.2 million associated with the settlement of customer claims and the shutdown of the aluminum extrusions manufacturing facility in Kentland, Indiana. |
(c) | Goodwill impairment charge of $46.8 million ($38.2 million after deferred income tax benefits) recognized in the Personal Care component of PE Films in the third quarter of 2018 upon the completion of an impairment analysis performed as of September 30, 2018. This non-operating, non-cash charge, as computed under GAAP, resulted from the expectation of a significant customer transition. The Company performed an asset recoverability test and goodwill impairment analysis and concluded that the fair value of the Personal Care reporting unit was less than its carrying value. | |
(d) | Unrealized pre-tax gains on the Company’s investment in kaleo, Inc. (“kaléo”) of $18.7 million and $30.6 million were recognized in the fourth quarter and full year of 2018, respectively (included in “Other income (expense), net” in the condensed consolidated statements of income), compared to unrealized pre-tax gains of $9.0 million and $33.8 million in the fourth quarter and full year of 2017, respectively. See Note 4 to the Notes to Financial Statements included in the 2018 Form 10-K for more information on the methods used to estimate the value of the Company’s investment in kaléo. A pre-tax loss on the Company’s investment in the Harbinger Capital Partners Special Situations Fund, L.P. of $0.5 million was recognized in 2018 (included in “Other income (expense), net” in the condensed consolidated statements of income) (none in 2017). | |
(e) | The Company recorded an unrealized pre-tax loss on its investment property in Alleghany and Bath Counties, Virginia (included in “Other income (expense), net” in the condensed consolidated statements of income) of $0.2 million in the third quarter of 2018. This loss was recognized when the property was sold in the fourth quarter of 2018. | |
(f) | During 2018, the Company recorded a deferred tax expense of $0.6 million as a valuation allowance to offset deferred tax assets related to capital losses which the Company does not believe are more likely than not to be recognized prior to expiration of the carryover period. During the fourth quarter of 2017, in conjunction with annual business planning as well as valuation activities and other efforts, the Company claimed an ordinary loss for U.S. federal and state income tax purposes of $153 million for the write-off of the stock basis of Terphane Limitada (Terphane’s Brazilian entity). The Terphane Limitada worthless stock deduction resulted in an overall reduction of Tredegar’s U.S. income tax liability by approximately $49 million. Tax benefits of $36 million were realized in 2018, with most of the remaining balance of $13 million expected to be realized in cash in 2019. During the second quarter of 2017, the Company recognized a worthless stock deduction for Terphane, Inc. (Terphane’s U.S. affiliate), which resulted in an income tax benefit recognized of $8.1 million. Also during the second quarter of 2017, the Company recognized a net tax benefit of $0.4 million associated with additional U.S. tax related to the repatriation of cash from Brazil in the third quarter of 2016 offset by the reversal of related tax contingencies. | |
(g) |
Net debt is calculated as follows: |
(in millions) | December 31, 2018 | December 31, 2017 | |||||||||
Debt | $ | 101.5 | $ | 152.0 | |||||||
Less: Cash and cash equivalents | 34.4 | 36.5 | |||||||||
Net debt | $ | 67.1 | $ | 115.5 | |||||||
Net debt is not intended to represent total debt as defined by GAAP. Net debt is utilized by management in evaluating the Company’s financial leverage and equity valuation, and management believes that investors also may find net debt to be helpful for the same purposes. |
||
(h) | Tredegar’s presentation of net income and earnings per share from ongoing operations are non-GAAP financial measures that exclude the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges and other items (which includes unrealized gains and losses for an investment accounted for under the fair value method), which have been presented separately and removed from net income (loss) and diluted earnings (loss) per share as reported under GAAP. Net income and earnings per share from ongoing operations are key financial and analytical measures used by management to gauge the operating performance of Tredegar’s ongoing operations. They are not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) or earnings (loss) per share as defined by GAAP. They exclude items that we believe do not relate to Tredegar’s ongoing operations. A reconciliation of the pre-tax and post-tax balances attributed to net income from ongoing operations for the three and twelve months ended December 31, 2018 and 2017 are shown below in order to show the impact on the effective tax rate (due to rounding, numbers presented in this table may not add up precisely to the totals provided): | |
(In millions) | Pre-Tax |
Taxes Expense |
After-Tax |
Effective |
||||||||||||||||
Three Months Ended December 31, 2018 | (a) | (b) | (b)/(a) | |||||||||||||||||
Net income (loss) reported under GAAP | $ | 34.5 | $ | 8.4 | $ | 26.2 | 24.3 | % | ||||||||||||
Losses associated with plant shutdowns, asset |
1.3 | 0.1 | 1.2 | |||||||||||||||||
(Gains) losses from sale of assets and other | (17.2 | ) | (4.0 | ) | (13.2 | ) | ||||||||||||||
Net income from ongoing operations | $ | 18.6 | $ | 4.5 | $ | 14.2 | 23.8 | % | ||||||||||||
Three Months Ended December 31, 2017 | ||||||||||||||||||||
Net income reported under GAAP | $ | (80.8 | ) | $ | (62.9 | ) | $ | (17.9 | ) | 77.8 | % | |||||||||
Losses associated with plant shutdowns, asset |
101.8 | 14.1 | 87.7 | |||||||||||||||||
(Gains) losses from sale of assets and other | (9.5 | ) | 53.9 | (63.4 | ) | |||||||||||||||
Net income from ongoing operations | $ | 11.5 | $ | 5.1 | $ | 6.4 | 44.4 | % | ||||||||||||
Twelve Months Ended December 31, 2018 | ||||||||||||||||||||
Net income (loss) reported under GAAP | $ | 36.4 | $ | 11.5 | $ | 24.8 | 31.7 | % | ||||||||||||
Losses associated with plant shutdowns, asset |
4.1 | 0.2 | 3.8 | |||||||||||||||||
(Gains) losses from sale of assets and other | (25.9 | ) | (6.4 | ) | (19.5 | ) | ||||||||||||||
Goodwill impairment charge | 46.8 | 8.6 | 38.2 | |||||||||||||||||
Net income from ongoing operations | $ | 61.4 | $ | 13.9 | $ | 47.3 | 22.8 | % | ||||||||||||
Twelve Months Ended December 31, 2017 | ||||||||||||||||||||
Net income reported under GAAP | $ | (14.9 | ) | $ | (53.2 | ) | $ | 38.3 | 356.5 | % | ||||||||||
Losses associated with plant shutdowns, asset |
103.3 | 14.7 | 88.6 | |||||||||||||||||
(Gains) losses from sale of assets and other | (39.1 | ) | 57.7 | (96.8 | ) | |||||||||||||||
Net income from ongoing operations | $ | 49.3 | $ | 19.2 | $ | 30.1 | 39.0 | % | ||||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20190318005728/en/
Source:
Tredegar Corporation
Neill Bellamy, 804-330-1211
neill.bellamy@tredegar.com